Chabiotech Co.,Ltd.
Develops cell/gene therapies and provides CDMO and bio-banking services.
085660 | KO
Overview
Corporate Details
- ISIN(s):
- KR7085660009
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 도산대로 442 청담동 피엔폴루스 3층, 강남구
- Website:
- http://en.chabio.com/
Description
Chabiotech Co., Ltd. is a biotechnology company specializing in the research and development of cell and gene therapies for rare cancers and incurable diseases. The company's core activities include advancing its therapeutic pipelines and providing global Contract Development and Manufacturing Organization (CDMO) services for advanced biopharmaceuticals, including full-scale GMP production and testing. Chabiotech also operates bio-banking services, such as cord blood and immune/stem cell storage, utilizing advanced cryopreservation technology. Its diversified business segments extend to genomics for precision medicine, healthcare IT solutions that integrate AI and Big Data, comprehensive wellness programs, and specialized healthcare consulting.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-07-09 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 181.2 KB | ||
| 2020-06-26 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 211.3 KB | ||
| 2020-06-24 00:00 |
기타경영사항(특허권취득)(자율공시)(향상된 산후 부착형 세포 및 그의 제조 방법)
|
Korean | 6.4 KB | ||
| 2020-06-19 00:00 |
증권발행결과(자율공시)(제6회차 CB)
|
Korean | 6.0 KB | ||
| 2020-06-19 00:00 |
증권발행결과(자율공시)(제7회차 BW)
|
Korean | 6.1 KB | ||
| 2020-06-18 00:00 |
[기재정정]주요사항보고서(신주인수권부사채권발행결정)
|
Korean | 48.0 KB | ||
| 2020-06-17 00:00 |
주요사항보고서(전환사채권발행결정)
|
Korean | 37.6 KB | ||
| 2020-06-17 00:00 |
주요사항보고서(신주인수권부사채권발행결정)
|
Korean | 46.1 KB | ||
| 2020-05-21 00:00 |
기타경영사항(특허권취득)(자율공시)
|
Korean | 6.6 KB | ||
| 2020-05-14 00:00 |
분기보고서 (2020.03)
|
Korean | 2.3 MB | ||
| 2020-04-27 00:00 |
투자판단관련주요경영사항(고형암 환자를 대상으로 'CBT101'의 내약성 및 안전성을 평가하는 임상1상 임상시험계획 신청)
|
Korean | 11.3 KB | ||
| 2020-04-23 00:00 |
투자판단관련주요경영사항('퇴행성 요추 추간판으로 인한 만성 요통 환자'에 대한 'CordSTEM-DD' 임상 1/2a상 임상시험계획의 변경 승…
|
Korean | 14.8 KB | ||
| 2020-04-17 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 168.5 KB | ||
| 2020-04-08 00:00 |
기타경영사항(특허권취득)(자율공시)
|
Korean | 6.2 KB | ||
| 2020-03-30 00:00 |
사업보고서 (2019.12)
|
Korean | 760.4 KB |
Automate Your Workflow. Get a real-time feed of all Chabiotech Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Chabiotech Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Chabiotech Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
